
IOL Advances
Latest News
Advertisement
CME Content
Advertisement



















Lens is offering patines improved refractive, visual outcomes following cataract surgery.



A study reviews the results, and patient satisfaction following bilateral implantation of an extended depth of focus intraocular lens.

Alcon has received FDA approval for its AcrySof IQ PanOptix Trifocal IOL, and the company is rolling out its initial commercial launch of the product.

Annual survey from ASCRS/ESCRS pinpoints trends in explantation

A diffractive trifocal IOL achieved satisfactory vision with a high rate of spectacle independence
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
Retinal imaging as a window into atrial fibrillation
2
First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP
3
OCT-980 receives FDA orphan drug designation for retinitis pigmentosa
4
Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery
5







